TABLE 2.
Comparison of in‐hospital mortality and LOS (in days) among convalescent plasma recipients and controls
| Expired, n (%) | p | LOS, median (IQR) | P | |
|---|---|---|---|---|
| Study Group | ||||
| Convalescent Plasma | 7 (20.0) | 0.61 | 10 (6–17) | <.01 |
| Control | 15 (24.6) | 7 (4–11) | ||
| Age Group | ||||
| < 65 years old | 5 (8.2) | <0.01 | 8 (4–11) | .47 |
| ≥ 65 years old | 17 (48.6) | 8 (5‐15) | ||
| Gender | ||||
| Female | 11 (23.4) | 0.91 | 8 (4–11) | .72 |
| Male | 11 (22.5 | 8 (4‐13) | ||
| Racial/ethnic group | ||||
| African‐American | 2 (11.8) | 0.14 | 8 (4‐16) | .89 |
| Caucasian | 14 (34.2) | 7 (4–13) | ||
| Hispanic/Latino | 5 (17.9) | 8.5 (5‐11) | ||
| Other/Unknown | 1 (10.0) | 7.5 (6–10 | ||
| Hospital | ||||
| Danbury Hospital | 8 (22.9) | 0.95 | 7 (3‐10) | .11 |
| Norwalk Hospital | 8 (24.2) | 9 (6–11) | ||
| Vassar Brothers Medical Center | 5 (20.0) | 10 (6–19) | ||
| Putnam and Sharon Hospitals | 1 (33.3) | 16 (5‐17) | ||
| Intubation | ||||
| Yes | 8 (42.1) | <0.01 | 14 (11‐20) | <.01 |
| No | 14 (18.2) | 6 (4‐10) | ||
| Systemic steroids | ||||
| Yes | 12 (48.0) | 0.03 | 13 (7‐20) | .02 |
| No | 10 (14.1) | 8 (4–11) | ||
| Therapeutic anticoagulation | ||||
| Yes | 9 (25.7) | 0.62 | 12 (7‐20) | <.01 |
| No | 13 (21.3) | 6 (4–10) | ||
| IL‐6 Inhibitor | ||||
| Yes | 2 (15.4) | 0.49 | 9 (8–12) | .28 |
| No | 20 (12.1) | 8 (4–11) | ||
| Diabetes mellitus | ||||
| Yes | 11 (36.7) | 0.03 | 9.5 (6‐20) | .03 |
| No | 11 (16.7) | 7.5 (4–10) | ||
| Hypertension | ||||
| Yes | 10 (20.8) | 0.63 | 8.5 (6‐14.5) | .05 |
| No | 12 (25.0) | 6.5 (4‐10.5) | ||
| Congestive heart failure | ||||
| Yes | 2 (22.2) | 0.96 | 7 (3‐15) | .72 |
| No | 20 (23.0) | 8 (1‐12) |